AMSilk’s bioengineered silk protein yarns debut in Balenciaga Spring 2026 Collection
- First commercially available products using AMSilk’s biotech silk protein yarns
- Demonstrating a scalable, low impact alternative to conventional silk within luxury fashion
- Designed for resilient, transparent and regionally integrated supply chains
Neuried, Germany, January 21, 2026 – AMSilk GmbH (“AMSilk”), a global leader in advanced biomaterials made from silk proteins, today announced that its bioengineered yarns are featured in commercially available garments within Balenciaga’s Spring 2026 collection.
